At the time of writing, Agios Pharmaceuticals Inc [AGIO] stock is trading at $42.43, down -0.40%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AGIO shares have gain 6.26% over the last week, with a monthly amount glided 18.92%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Agios Pharmaceuticals Inc [NASDAQ: AGIO] stock has seen the most recent analyst activity on February 24, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $58. Leerink Partners downgraded its rating to a Market Perform and decreased its price target to $56 on September 27, 2024. Cantor Fitzgerald initiated its recommendation with a Overweight. Piper Sandler started tracking with a Overweight rating for this stock on February 03, 2023, and assigned it a price target of $41. In a note dated November 17, 2022, Goldman upgraded an Neutral rating on this stock and boosted its target price from $17 to $32.
For the past year, the stock price of Agios Pharmaceuticals Inc fluctuated between $23.42 and $62.58. Currently, Wall Street analysts expect the stock to reach $71 within the next 12 months. Agios Pharmaceuticals Inc [NASDAQ: AGIO] shares were valued at $42.43 at the most recent close of the market. An investor can expect a potential return of 67.33% based on the average AGIO price forecast.
Analyzing the AGIO fundamentals
According to Agios Pharmaceuticals Inc [NASDAQ:AGIO], the company’s sales were 40.88M for trailing twelve months, which represents an 44.57% jump. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -11.29%, Pretax Profit Margin comes in at 16.99%, and Net Profit Margin reading is 15.9%. To continue investigating profitability, this company’s Return on Assets is posted at 0.44, Equity is 0.43 and Total Capital is -0.33. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 41.83 points at the first support level, and at 41.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 43.12, and for the 2nd resistance point, it is at 43.81.
Ratios To Look Out For
It is important to note that Agios Pharmaceuticals Inc [NASDAQ:AGIO] has a current ratio of 14.48. Also, the Quick Ratio is 14.04, while the Cash Ratio stands at 1.15. Considering the valuation of this stock, the price to sales ratio is 60.30, the price to book ratio is 1.80 and price to earnings (TTM) ratio is 3.84.
Transactions by insiders
Recent insider trading involved DAVID SCADDEN, Director, that happened on Oct 08 ’25 when 200.0 shares were purchased. Director, Scadden David completed a deal on Sep 30 ’25 to sell 200.0 shares. Meanwhile, Chief Financial Officer Jones Cecilia sold 3651.0 shares on Sep 26 ’25.
